Le Pharmacien Hospitalier最新文献

{"title":"L’entreprise face aux marchés publics hospitaliers dématérialisés, état des lieux à l’orée 2010 et comparaison des différentes plateformes","authors":"Th. Amadieu , Th. Beaugé","doi":"10.1016/S0768-9179(10)70007-9","DOIUrl":"10.1016/S0768-9179(10)70007-9","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Pages 27-33"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70007-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80538209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La dématérialisation des marchés hospitaliers : état des lieux à l’orée de 2010","authors":"P. Paubel , T. Beaugé","doi":"10.1016/S0768-9179(10)70002-X","DOIUrl":"10.1016/S0768-9179(10)70002-X","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Page 3"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70002-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"103379703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Conclusion","authors":"T. Beaugé , P. Paubel","doi":"10.1016/S0768-9179(10)70017-1","DOIUrl":"https://doi.org/10.1016/S0768-9179(10)70017-1","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Page 74"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70017-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138314249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La dématérialisation des marchés publics en France au 1er janvier 2010","authors":"C. Alviset","doi":"10.1016/S0768-9179(10)70004-3","DOIUrl":"10.1016/S0768-9179(10)70004-3","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Pages 10-15"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70004-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75392295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La démarche chez Lilly France","authors":"M. Danon","doi":"10.1016/S0768-9179(10)70012-2","DOIUrl":"10.1016/S0768-9179(10)70012-2","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Pages 52-55"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70012-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87108294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La démarche chez Covidien","authors":"S. Nivaux","doi":"10.1016/S0768-9179(10)70013-4","DOIUrl":"10.1016/S0768-9179(10)70013-4","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Pages 56-60"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70013-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86490271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Présentation d’une enquête sur l’état d’avancement de la dématérialisation des marchés publics hospitaliers","authors":"P. Paubel","doi":"10.1016/S0768-9179(10)70015-8","DOIUrl":"10.1016/S0768-9179(10)70015-8","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Pages 63-64"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70015-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79655578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La démarche du RESAH-IDF, segment Médicaments","authors":"J.-L. Pons","doi":"10.1016/S0768-9179(10)70010-9","DOIUrl":"10.1016/S0768-9179(10)70010-9","url":null,"abstract":"","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 ","pages":"Pages 45-47"},"PeriodicalIF":0.0,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0768-9179(10)70010-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133360042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Soins pharmaceutiques en gynécologie-obstétrique : à propos d’un cas","authors":"S. Skalli ,&nbsp;E. Ferreira ,&nbsp;J.F. Bussieres ,&nbsp;B. Allenet","doi":"10.1016/j.phhp.2010.07.008","DOIUrl":"10.1016/j.phhp.2010.07.008","url":null,"abstract":"<div><p>L’avènement de pharmaciens dans les services de soins vers le début des années 1990 a grandement contribué au rayonnement des activités pharmaceutiques dans les établissements de santé en Amérique du Nord. Le CHU Sainte-Justine a vu ainsi l’implantation de la pharmacie clinique et son développement, lequel a abouti depuis quelques années à l’émergence de soins pharmaceutiques spécialisés adaptés aux besoins des équipes de soins et aux profils des patients. Le service de gynécologie-obstétrique, appuyé notamment par la création d’une chaire pharmaceutique, a bénéficié des activités du pharmacien clinicien qui est devenu rapidement un membre incontournable pour une prise en charge thérapeutique efficiente. Nous présentons, au travers d’un cas clinique d’une patiente enceinte exposée à l’azathioprine dans le cadre de son lupus érythémateux, des exemples d’interventions pharmaceutiques pouvant être effectués par le pharmacien clinicien dans le cadre de sa démarche de soins auprès des patients et des professionnels de santé.</p></div><div><p>Beginning in the 1990s, clinical pharmacy has greatly contributed to the development of hospital pharmacy practice in North America. Clinical pharmacy was implemented at CHU Sainte-Justine to promote rational and appropriate use of drug therapy. The department of obstetrics-gynecology, supported notably by the creation of a pharmaceutical Chair, has benefited from the services of a clinical pharmacist since 1998. We present, through a case report of pregnant woman treated with azathioprine for lupus erythematosus, pharmaceutical interventions by the clinical pharmacist on the obstetrics and gynaecology ward as part of his interactions with patients, physicians and other healthcare professionals.</p></div>","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 3","pages":"Pages 117-123"},"PeriodicalIF":0.0,"publicationDate":"2010-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.phhp.2010.07.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74650031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Indicateurs d’efficience et de sécurité pour la traçabilité des dispositifs médicaux implantables","authors":"H. Mockly-Postal ,&nbsp;M. Jehl-Rave ,&nbsp;M.-H. Choulet ,&nbsp;A. Grumblat ,&nbsp;S. Limat","doi":"10.1016/j.phhp.2010.07.012","DOIUrl":"10.1016/j.phhp.2010.07.012","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;p&gt;Ce travail a pour objectif de faire un état des lieux qualitatif et quantitatif et d’étudier l’intérêt d’un suivi régulier de trois séries d’implants : série 1 – implants « déstérilisés » ou échec de pose (ID), série 2 – implants déstérilisés ou échec de pose relevant d’un incident de « matériovigilance » (IM) et série 3 – implants « non tracés » (INT).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodologie&lt;/h3&gt;&lt;p&gt;Extraction sur 2007 des trois séries à partir des bases de données de traçabilité ; classement et valorisation selon les classes d’implants, les pôles d’activité et le type de prise en charge (en sus ou compris dans les groupes homogènes de séjour [GHS]).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;p&gt;En 2007, 10 087 implants stériles ont été tracés pour une valeur de 4 394 608 € toutes taxes comprises (TTC). Un tiers est facturable en sus des GHS. La proportion des séries 1, 2 et 3 est, respectivement, de 3,2 % avec 318 ID, 0,1 % avec 13 IM et 1 % avec 105 INT. La valeur TTC de chacune des séries est, respectivement, de 108 956 €, 11 219 € et 28 613 €. Pour les séries 1 et 3, 80 % sont potentiellement facturables en sus des GHS. Les histogrammes cumulés par classe d’implants montrent, dans les séries 1 et 3, les classes d’implants à suivre.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Discussion et conclusion&lt;/h3&gt;&lt;p&gt;Le taux de ID et INT peut être un indicateur de suivi annuel des dépenses liées aux implants et de mise en évidence des dérives liées aux pratiques. La réduction de ces pertes nécessiterait une analyse plus fine par spécialité pour évaluer la part évitable.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;The aim of this work is to make a qualitative and quantitative state of the art and to evaluate the interest to regularly follow through three groups of implantable medical devices: group 1 – desterilized implants or placement failure (DI), group 2 – desterilized implants or implants not placed due to incident of medical devices vigilance (IMDV) and group 3 – implants with unknown beneficiary patient (UB).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methodology&lt;/h3&gt;&lt;p&gt;Determination of the three groups from our 2007 traceability databases; each implant was classified and its cost evaluated, based on its class, the medical pole and the type of financing (outside or included in the GHS).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;In 2007, 10,087 sterile implants have been recorded corresponding to 4,394,608 € TTC. A third is charged outside the GHS. Among them, we found respectively 3.2% (318) of DI, 0.1% (13) of IMDV and 1% (105) of UB. This cost raised (inclusive of tax) 108,956 €, 11,219 € and 28,613 €, respectively. In groups 1 and 3, 80% of the devices should have been charged outside the GHS. Diagrams bring to light which classes of implants should be checked.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Discussion and conclusion&lt;/h3&gt;&lt;p&gt;The rate of DI and UB appeared as valuable indicators for the monitoring of expenditures linked to implants. A more accurate analysis that takes into account different medical speciality should be pe","PeriodicalId":100871,"journal":{"name":"Le Pharmacien Hospitalier","volume":"45 3","pages":"Pages 108-116"},"PeriodicalIF":0.0,"publicationDate":"2010-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.phhp.2010.07.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85462535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}